Guanadrel
Names | |
---|---|
IUPAC name
2-(1,4-Dioxaspiro[4.5]decan-2-ylmethyl)guanidine
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
IUPHAR/BPS |
|
KEGG | |
MeSH | C004945 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C10H19N3O2 | |
Molar mass | 213.281 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Guanadrel is an
.Mechanism of action
Guanadrel is a postganglionic adrenergic blocking agent. Uptake of guanadrel and storage in sympathetic neurons occurs via the
sympathetic nerve stimulation, as a result of catecholamine depletion, leads to reduced arteriolar vasoconstriction, especially the reflex increase in sympathetic tone that occurs with a change in position. Guanadrel is rapidly and well absorbed from gastrointestinal tract.[2]
In 1981 the
JAMA reported guanadrel as an effective step II or step III treatment of hypertension.[3]
References
- PMID 4031111.[permanent dead link]
- ^ Guanadrel, from Pharmacogenetics Knowledge Base
- PMID 7206175.